Investigation of the binding of virulence factors of important infectious pathogens with proinflammatory lipid molecules: Establishment of a novel mechanism of pathogen’s evasion of host defense and Search for new targets for therapeutic development
Antibiotics-resistant bacterial infection becomes one of the major threats both locally and in the world. The increasing incidences of hospital-acquired and community-acquired cases of multi-drug resistant bacterial infections have alerted our community that these pathogens are quickly and increasingly resistant to multi-antibiotics currently used and antibiotics-resistant bacterial infection could develop into a serious epidemic situation. Therefore, there is an urgent need to look for new approaches and druggable targets for combating multi-drug resistant bacteria. We aim to carry out structure-function studies on the virulence factors of a number of important pathogens, including multidrug resistant Staphylococcus aureus, Mycobacterium tuberculosis,Legionella pneumophila, Penicillium marneffei and Aspergillus fumigatus then carry out in silico structure-based screening against a library of available compounds to develop drug inhibitors against these virulence factors of the pathogens.
Objectives: (1) Target virulence factor identification by clinical information combined with literature search and bioinformatics approaches, including sequence homology, structure homology and molecular docking. (2) Structure function studies of of virulence factor-lipid interaction (3) Drug lead development by in-silico structure-based screening and characterization of the inhibitors of target virulence factor.